{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:52:18Z","timestamp":1790848338597,"version":"4.1.0"},"reference-count":40,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"unspecified","delay-in-days":98,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Queen Mary University of London: Queen Mary Impact Fund","award":["PSF0148R"],"award-info":[{"award-number":["PSF0148R"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2026,2,4]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Recreational use of nitrous oxide (N\n                      <jats:sub>2<\/jats:sub>\n                      O) has risen markedly over the past decade; typically, users are young adults, often from ethnic minority backgrounds and not in full-time employment. Prolonged or intense N\n                      <jats:sub>2<\/jats:sub>\n                      O use can inactivate vitamin B\n                      <jats:sub>12<\/jats:sub>\n                      , leading to subacute combined degeneration of the spinal cord, which may result in significant neurological disability. Understanding N\n                      <jats:sub>2<\/jats:sub>\n                      O-related health and social harms remains challenging due to limited patient engagement with research and healthcare.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Drawing on our experience of conducting a longitudinal study and existing literature, we offer practical recommendations for researchers and clinicians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Inclusive research practices that incorporate lived experience perspectives are essential to enhance relevance and accessibility. Offering compensation, psychological support resources and flexible delivery models may improve recruitment and retention. Confidentiality limits must be clearly communicated, particularly when illegal activity may be disclosed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Strengthening engagement in research will inform evidence-based practice within healthcare systems. Additionally, we advocate for better training on N\n                      <jats:sub>2<\/jats:sub>\n                      O-related harms and multidisciplinary collaboration to enhance healthcare provision.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial registration number<\/jats:bold>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05714917\">NCT05714917<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001522","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:06:26Z","timestamp":1775750786000},"page":"e001522","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Inclusive approaches to research and healthcare for nitrous oxide users: lessons from a longitudinal study"],"prefix":"10.1136","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct05714917","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0050-5669","authenticated-orcid":false,"given":"Aimee","family":"Hibbert","sequence":"first","affiliation":[{"name":"Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK"},{"name":"Clinical Neurology, Queens Medical Centre, Nottingham University Hospitals, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6112-4830","authenticated-orcid":false,"given":"Mohamoud","family":"Hashi","sequence":"additional","affiliation":[{"name":"Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK"},{"name":"Department of Neurology, The Royal London Hospital, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Symes","sequence":"additional","affiliation":[{"name":"Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Hayton","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Lilleker","sequence":"additional","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Dodd","sequence":"additional","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Evangelou","sequence":"additional","affiliation":[{"name":"Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK"},{"name":"Clinical Neurology, Queens Medical Centre, Nottingham University Hospitals, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair J","family":"Noyce","sequence":"additional","affiliation":[{"name":"Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK"},{"name":"Department of Neurology, The Royal London Hospital, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J","family":"Smith","sequence":"additional","affiliation":[{"name":"Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"2026051208153980000_8.1.e001522.1","unstructured":"Aerts L , Morais J , Evans-Brown M , et al . Recreational use of nitrous oxide: a growing concern for Europe. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg; 2022.88. Available: https:\/\/oceanrep.geomar.de\/id\/eprint\/57668\/"},{"key":"2026051208153980000_8.1.e001522.2","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2022-003631"},{"key":"2026051208153980000_8.1.e001522.3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-331131"},{"key":"2026051208153980000_8.1.e001522.4","unstructured":"Winstock A , Munksgaard R , Davies E , et al . Drug trend report: time, music, clubbing, age, and diet. Global Drug Survey; 2022. Available: https:\/\/poradniauzaleznienia.pl\/wp-content\/uploads\/pdf\/2022WowReport_Final.pdf"},{"key":"2026051208153980000_8.1.e001522.5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2024-000737","article-title":"Evaluation of an ambulatory care pathway for patients with nitrous oxide-induced myeloneuropathy","volume":"6","author":"Zaloum","year":"2024","journal-title":"BMJ Neurol Open"},{"key":"2026051208153980000_8.1.e001522.6","first-page":"13","article-title":"Not a Laughing Matter: When Nitrous Oxide Causes Functional Vitamin B12 Deficiency","volume":"107","author":"Daniel","year":"2024","journal-title":"R I Med J (2013)"},{"key":"2026051208153980000_8.1.e001522.7","unstructured":"Home Office . Nitrous oxide ban: guidance. 2023. Available: https:\/\/www.gov.uk\/government\/publications\/nitrous-oxide-ban\/nitrous-oxide-ban-guidance#changes-made-to-the-law"},{"key":"2026051208153980000_8.1.e001522.8","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(24)00298-6"},{"key":"2026051208153980000_8.1.e001522.9","unstructured":"Home Office . Nitrous oxide: legitimate uses and appropriate controls. 2023. Available: https:\/\/www.gov.uk\/government\/consultations\/nitrous-oxide-legitimate-uses-and-appropriate-controls\/nitrous-oxide-legitimate-uses-and-appropriate-controls"},{"key":"2026051208153980000_8.1.e001522.10","doi-asserted-by":"publisher","DOI":"10.1111\/1742-6723.13997"},{"key":"2026051208153980000_8.1.e001522.11","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1167746","article-title":"Nitrous oxide: a unique official French addictovigilance national survey","volume":"11","author":"Guerlais","year":"2023","journal-title":"Front Public Health"},{"key":"2026051208153980000_8.1.e001522.12","unstructured":"Health Research Authority . Public perceptions of research. 2024. Available: https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/best-practice\/public-perceptions-research"},{"key":"2026051208153980000_8.1.e001522.13","doi-asserted-by":"publisher","DOI":"10.3310\/hta22440"},{"key":"2026051208153980000_8.1.e001522.14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-0044-1782516","article-title":"Underrepresented and Underserved Populations in Neurological Research","volume":"44","author":"Windon","year":"2024","journal-title":"Semin Neurol"},{"key":"2026051208153980000_8.1.e001522.15","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1177\/13524585241277018","article-title":"The relationship between ethnicity and multiple sclerosis characteristics in the United Kingdom: A UK MS Register study","volume":"30","author":"Jacobs","year":"2024","journal-title":"Mult Scler"},{"key":"2026051208153980000_8.1.e001522.16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ajad.13363","article-title":"A cross-sectional study: Nitrous oxide abuse in Parisian medical students","volume":"32","author":"Cohen","year":"2023","journal-title":"Am J Addict"},{"key":"2026051208153980000_8.1.e001522.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247230","article-title":"Associations of socio-demographic characteristics, well-being, school absenteeism, and substance use with recreational nitrous oxide use among adolescents: A cross-sectional study","volume":"16","author":"van den Toren","year":"2021","journal-title":"PLoS One"},{"key":"2026051208153980000_8.1.e001522.18","doi-asserted-by":"crossref","DOI":"10.1186\/s42238-019-0009-6","article-title":"A smartphone app intervention for adult cannabis users wanting to quit or reduce their use: a pilot evaluation","volume":"1","author":"Albertella","year":"2019","journal-title":"J Cannabis Res"},{"key":"2026051208153980000_8.1.e001522.19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40122-019-0133-1","article-title":"Associations Between Headache-Free Days and Patient-Reported Outcomes Among Migraine Patients: A Cross-Sectional Analysis of Survey Data in Europe","volume":"8","author":"Doane","year":"2019","journal-title":"Pain Ther"},{"key":"2026051208153980000_8.1.e001522.20","doi-asserted-by":"crossref","first-page":"105648","DOI":"10.1016\/j.msard.2024.105648","article-title":"Prevalence, treatment and correlates of depression in multiple sclerosis","volume":"87","author":"Young","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"2026051208153980000_8.1.e001522.21","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2023.654","article-title":"The UK National Recovery Survey: nationally representative survey of people overcoming a drug or alcohol problem","volume":"10","author":"Day","year":"2024","journal-title":"BJPsych Open"},{"key":"2026051208153980000_8.1.e001522.22","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001151"},{"key":"2026051208153980000_8.1.e001522.23","doi-asserted-by":"publisher","DOI":"10.1111\/add.16380"},{"key":"2026051208153980000_8.1.e001522.24","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18115574","article-title":"Problematic Use of Nitrous Oxide by Young Moroccan-Dutch Adults","volume":"18","author":"Nabben","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026051208153980000_8.1.e001522.25","doi-asserted-by":"publisher","DOI":"10.3109\/10673229709030550"},{"key":"2026051208153980000_8.1.e001522.26","doi-asserted-by":"crossref","DOI":"10.2196\/58258","article-title":"Determinants of Dropping Out of Remote Patient-Reported Outcome\u2013Based Follow-Up Among Patients With Epilepsy: Prospective Cohort Study","volume":"9","author":"Vestergaard","year":"2025","journal-title":"JMIR Form Res"},{"key":"2026051208153980000_8.1.e001522.27","doi-asserted-by":"publisher","DOI":"10.1111\/head.13911"},{"key":"2026051208153980000_8.1.e001522.28","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-015-0552-2"},{"key":"2026051208153980000_8.1.e001522.29","unstructured":"Transform Drug Policy Foundation . Best practice guidelines for research around drugs issues. 2024. Available: https:\/\/transformdrugs.org\/assets\/files\/Best-Practice-Guidelines-for-Research-Around-Drugs-Issues-2024.pdf"},{"key":"2026051208153980000_8.1.e001522.30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12910-016-0108-2","article-title":"The ethics of community-based research with people who use drugs: results of a scoping review","volume":"17","author":"Souleymanov","year":"2016","journal-title":"BMC Med Ethics"},{"key":"2026051208153980000_8.1.e001522.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2025-001234","article-title":"Evaluation of outcomes for patients with nitrous oxide-related myeloneuropathy treated with self-injection of hydroxocobalamin versus nurse-led injections on an ambulatory care pathway","volume":"7","author":"Hashi","year":"2025","journal-title":"BMJ Neurol Open"},{"key":"2026051208153980000_8.1.e001522.32","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300116"},{"key":"2026051208153980000_8.1.e001522.33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s10194-020-01177-4","article-title":"Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study","volume":"21","author":"Buse","year":"2020","journal-title":"J Headache Pain"},{"key":"2026051208153980000_8.1.e001522.34","doi-asserted-by":"crossref","DOI":"10.2196\/27735","article-title":"Attrition Within Digital Health Interventions for People With Multiple Sclerosis: Systematic Review and Meta-analysis","volume":"24","author":"Bevens","year":"2022","journal-title":"J Med Internet Res"},{"key":"2026051208153980000_8.1.e001522.35","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.2256","article-title":"Effectiveness of a self-guided web-based cannabis treatment program: randomized controlled trial","volume":"15","author":"Rooke","year":"2013","journal-title":"J Med Internet Res"},{"key":"2026051208153980000_8.1.e001522.36","unstructured":"Advisory Council on the Misuse of Drugs . Nitrous oxide: updated harms assessment. 2023. Available: https:\/\/www.gov.uk\/government\/publications\/nitrous-oxide-updated-harms-assessment"},{"key":"2026051208153980000_8.1.e001522.37","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8801-3"},{"key":"2026051208153980000_8.1.e001522.38","doi-asserted-by":"crossref","DOI":"10.3390\/toxics13060466","article-title":"Addressing the Global Challenge of Nitrous Oxide Misuse Through a Multidisciplinary Approach: Example of the PROTOSIDE Network","volume":"13","author":"Grzych","year":"2025","journal-title":"Toxics"},{"key":"2026051208153980000_8.1.e001522.39","unstructured":"UK Government . Drugs penalties. 2025. Available: https:\/\/www.gov.uk\/penalties-drug-possession-dealing"},{"key":"2026051208153980000_8.1.e001522.40","unstructured":"Walcott S . Rethinking drugs: criminalisation is causing harm. 2023. Available: https:\/\/revolving-doors.org.uk\/rethinking-drugs-criminalisation-is-causing-harm"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:17:35Z","timestamp":1778599055000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,9]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjno-2025-001522"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001522","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}